Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease.

Hamrahian AH, Yuen KC, Hoffman AR, For The Aace Neuroendocrine And Pituitary Scientific Committee.

Endocr Pract. 2014 Jul 1;20(7):746-57. doi: 10.4158/EP14147.RA.

PMID:
25057099
[PubMed - in process]
2.

Significant Hypercortisolism During Fractionated Radiotherapy in a Patient with a Large Corticotroph Adenoma: A Case Report and Literature Review.

Niwattisaiwong S, Suh JH, Weil RJ, Hamrahian AH.

Endocr Pract. 2014 Jun 16:1-15. [Epub ahead of print]

PMID:
24936553
[PubMed - as supplied by publisher]
3.

Ectopic ACTH-secreting pituitary adenomas within the sphenoid sinus.

Johnston PC, Kennedy L, Weil RJ, Hamrahian AH.

Endocrine. 2014 Jun 14. [Epub ahead of print]

PMID:
24927792
[PubMed - as supplied by publisher]
4.

Cushing's disease from an ectopic parasellar adenoma.

Johnston PC, Hamrahian AH, Weil RJ.

Postgrad Med J. 2014 Jun;90(1064):360-1. doi: 10.1136/postgradmedj-2014-132632. Epub 2014 Apr 29. No abstract available.

PMID:
24782548
[PubMed - in process]
5.

Bilateral posterior retroperitoneal robotic adrenalectomy for ACTH-independent Cushing syndrome.

Taskin HE, Aliyev S, Aksoy E, Hamrahian A, Siperstein A, Berber E.

Surg Laparosc Endosc Percutan Tech. 2014 Jun;24(3):e113-5. doi: 10.1097/SLE.0b013e31828fa7da.

PMID:
24710229
[PubMed - in process]
6.

Hurthle cell carcinoma presenting as a single choroid plexus metastasis.

Healy AT, Otvos B, Schroeder J, Hamrahian AH, Angelov L, Kamian K.

J Clin Neurosci. 2014 Aug;21(8):1448-50. doi: 10.1016/j.jocn.2013.12.012. Epub 2014 Jan 24.

PMID:
24656751
[PubMed - in process]
7.

Testicular "hyperstimulation" syndrome: a case of functional gonadotropinoma.

Thakkar A, Kannan S, Hamrahian A, Prayson RA, Weil RJ, Faiman C.

Case Rep Endocrinol. 2014;2014:194716. doi: 10.1155/2014/194716. Epub 2014 Jan 28.

PMID:
24592337
[PubMed]
Free PMC Article
8.

Biochemical and radiological relationships in patients with pheochromocytoma: lessons from a case control study.

Kannan S, Purysko A, Faiman C, Remer EM, Shah L, Bena J, Siperstein A, Berber E, Fergany A, Bravo E, Hamrahian AH.

Clin Endocrinol (Oxf). 2014 Jun;80(6):790-6. doi: 10.1111/cen.12420. Epub 2014 Mar 3.

PMID:
24494743
[PubMed - in process]
9.

Growth hormone should be used only for approved indications.

Clemmons DR, Molitch M, Hoffman AR, Klibanski A, Strasburger CJ, Kleinberg DL, Ho K, Webb SM, Bronstein MD, Bouillon R, Ben-Shlomo A, Hamrahian AH, Chanson P, Barkan AL, Merriam GR, Blackman MR, Salvatori R.

J Clin Endocrinol Metab. 2014 Feb;99(2):409-11. doi: 10.1210/jc.2013-4187. Epub 2013 Dec 11. No abstract available.

PMID:
24423315
[PubMed - indexed for MEDLINE]
10.

LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.

Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A, Watson CE, Maldonado M, Hamrahian AH, Boscaro M, Biller BM.

J Clin Endocrinol Metab. 2014 Apr;99(4):1375-83. doi: 10.1210/jc.2013-2117. Epub 2013 Dec 11.

PMID:
24423285
[PubMed - indexed for MEDLINE]
11.

High variability in baseline urinary free cortisol values in patients with Cushing's disease.

Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A, Biller BM; Pasireotide B2305 Study Group.

Clin Endocrinol (Oxf). 2014 Feb;80(2):261-9. doi: 10.1111/cen.12259. Epub 2013 Jul 15.

PMID:
23746264
[PubMed - in process]
Free Article
12.

Early radiological clues in diagnosis of adrenocortical carcinoma: lessons from a missed opportunity.

Kannan S, Siperstein A, Hamrahian AH.

Endocrine. 2013 Dec;44(3):817-8. doi: 10.1007/s12020-013-9978-y. Epub 2013 May 15. No abstract available.

PMID:
23673867
[PubMed - in process]
13.

A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults.

Yuen KC, Conway GS, Popovic V, Merriam GR, Bailey T, Hamrahian AH, Biller BM, Kipnes M, Moore JA, Humphriss E, Bright GM, Cleland JL.

J Clin Endocrinol Metab. 2013 Jun;98(6):2595-603. doi: 10.1210/jc.2013-1437. Epub 2013 Apr 12.

PMID:
23585663
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evaluation of patients with adrenal incidentalomas.

Kannan S, Remer EM, Hamrahian AH.

Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):161-9. doi: 10.1097/MED.0b013e328360a43b. Review.

PMID:
23571510
[PubMed - indexed for MEDLINE]
15.

Incidental lipid poor adrenal mass in a patient with antiphospholipid syndrome.

Kannan S, Satra A, Hamrahian A.

Case Rep Endocrinol. 2013;2013:379852. doi: 10.1155/2013/379852. Epub 2013 Feb 20.

PMID:
23509640
[PubMed]
Free PMC Article
16.

Absence of immunostaining for growth hormone in a subset of patients with acromegaly.

Schroeder JL, Spiotta AM, Fleseriu M, Prayson RA, Hamrahian AH, Weil RJ.

Pituitary. 2014 Apr;17(2):103-8. doi: 10.1007/s11102-013-0474-4.

PMID:
23475513
[PubMed - in process]
17.

Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?

Alkabbani AG, Mon SY, Hatipoglu B, Kennedy L, Faiman C, Weil RJ, Hamrahian AH.

Pituitary. 2014 Apr;17(2):97-102. doi: 10.1007/s11102-013-0473-5.

PMID:
23468127
[PubMed - in process]
18.

Determinants of weight gain in the action to control cardiovascular risk in diabetes trial.

Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC; ACCORD Study Group.

Diabetes Care. 2013 Aug;36(8):2162-8. doi: 10.2337/dc12-1391. Epub 2013 Feb 14.

PMID:
23412077
[PubMed - indexed for MEDLINE]
19.

Relapsing, remitting hypercortisolism in Cushing's disease due to intratumoral hemorrhages in pituitary microadenoma.

Marko NF, Hamrahian AH, Hatipoglu B, Weil RJ.

J Clin Neurosci. 2013 May;20(5):753-6. doi: 10.1016/j.jocn.2012.05.039. Epub 2013 Jan 24.

PMID:
23352667
[PubMed - indexed for MEDLINE]
20.

Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - a KIMS database analysis.

Tritos NA, Hamrahian AH, King D, Greenspan SL, Cook DM, Jönsson PJ, Koltowska-Häggstrom M, Biller BM.

Clin Endocrinol (Oxf). 2013 Aug;79(2):178-84. doi: 10.1111/cen.12132. Epub 2013 Apr 5.

PMID:
23278636
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk